The relationship between ACE gene insertion/deletion polymorphism and diabetic retinopathy in Iranian patients with type 2 diabetes

Ophthalmic Genetics

Volumn 31, Issue 3, 2010, Pages 108-113

  Nikzamir, Abdolrahim ^a,b   Rashidi, Armin ^b   Esteghamati, Alireza ^b   Nakhjavani, Manouchehr ^b   Golmohammadi, Taghi ^c   Khalilzadeh, Omid ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Albuminuria; Angiotensin converting enzyme; Diabetes; Polymorphism; Retinopathy

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ACE PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

ADULT; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENE ACTIVITY; GENE DELETION; GENE INSERTION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ALLELE; ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY CONSTITUTION; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY CONSTITUTION; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; GENE DELETION; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 77955526810     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.482554     Document Type: Article

References (53)

1. Fong DS, Aiello LP, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care 2004; 27:2540-2553.
2. Dodson PM. Diabetic retinopathy: treatment and prevention. Diab Vasc Dis Res 2007; 4 Suppl 3:S9-S11.
3. Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multiethnic cohort in the United States. Am J Ophthalmol 2006; 141:446-455.
4. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-652.
5. Klein R, Klein BE, Moss SE, et al. Glycosylated haemoglobin predicts the incidence and progression of diabetic retinopathy. Journal of the American Medical Association 1988;260:2864-2871.
6. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-1815.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993;329:977-986.
8. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647-661.
9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1998;317:703-713.
10. Klein BE, Moss SE, Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-1265.
11. Chew EY, Klein ML, Ferris FL 3rd, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Archives of Ophthalmology 1996;114:1079-1084.
12. Mathiesen ER, Ronn B, Storm B, et al. The natural course of microalbuminuria in insulin-dependent diabetes: a 10 year prospective study. Diabetic Medicine 1995;12:482-487.
13. Leslie RD, Pyke DA. Diabetic retinopathy in identical twins. Diabetes 1982;31:19-21.
14. Clermont A, Bursell SE, Feener EP. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond. Journal of Hypertension Suppl 2006;24:S73-80.
15. Migdalis IN, Iliopoulou V, Kalogeropoulou K, et al. Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy. Southern Medical Journal 1990;83:425-427.
16. Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, et al. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Diabetologia 2002;45:203-209.
17. Franken AA, Derkx FH, Blankestijn PJ, et al. Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus. Diabetes & Metabolism 1992;18:137-143.
18. Danser AH, van den Dorpel MA, Deinum J, et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J of Clinical Endocrinology & Metabolism 1989;68:160-167.
19. Franken AA, Derkx FH, Schalekamp MA, et al. Association of high plasma prorenin with diabetic retinopathy. Journal of Hypertension Suppl 1988;6:461-463.
20. Ohno T, Kawazu S, Tomono S. Association analysis of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 1996;45:218-222.
21. Doi Y, Yoshizumi M, Yoshinari K, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97-102.
22. Fernandez L, Twickler J, Mead A. Neovascularization produced by angiotensin II. Journal of Laboratory and Clinical Medicine 1985;105:141-145.
23. Le Noble FA, Hekking J, Van Straaten H, et al. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. European Journal of Pharmacology 1991;195:305-306.
24. Luetscher J, Kraemer F, Wilson D, et al. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. New England Journal of Medicine 1985;312:1412-1417.
25. Schalekamp M. Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease. Journal of Clinical Investigation 1993;71:S3-S6.
26. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 1990;86:1343-1346.
27. Nagi DK, Mansfield MW, Stickland MH, et al. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabetic Medicine 1995;12:997-1001.
28. Wu SS, Guo QM, Liu GL, et al. The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004;21:283-285.
29. Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998;41:47-53.
30. Gutierrez C, Vendrell J, Pastor R, et al. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 1997;46:976-980.
31. Fujisawa T, Ikegami H, Shen GQ, et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995;18:983-985.
32. Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism is correlated to diabetic retinopathy: a meta-analysis. Journal of Diabetes Complications 2008;22:144-146. (Pubitemid 351226613)
33. Soda S, Suzuki K, Aizawa Y. Polymorphisms in ACE gene deletion/insertion in type 2 diabetes. Nippon Rinsho 2005;63:198-201.
34. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-156.
35. Nikzamir A, Nakhjavani M, Golmohamadi T, et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Archives of Iranian Medicine 2008;11:3-9.
36. Lieberman J. Elevation of serum angiotensin-convertingenzyme (ACE) level in sarcoidosis. American Journal of Medicine 1975;59:365-372.
37. Lieberman J. The specificity and nature of serum- angiotensin- converting enzyme (serum ACE) elevations in sarcoidosis. Annals of the New York Academy of Science 1976;278:488-497.
38. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20.
39. Nakhjavani M, Esfahanian F, Jahanshahi A, et al. The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes. Nephrology Dialysis Transplantation 2007;22:2549-2553.
40. Nikzamir A, Nakhjavani M, Esteghamati A et al. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition. Nephrology Dialysis Transplantation 2008;23:1274-1277.
41. Feghhi M, Nikzamir A, Esteghamati A, et al. The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes. Diabetes Research and Clinical Practice 2008;81:1-4.
42. Globocnik-Petrovic M, Hawlina M, Peterlin B, et al. Insertion/ deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Ophthalmologica 2003;217:219-224.
43. Liao L, Lei M, Chen H, et al. Studies on ACE gene insertion/ deletion polymorphism, serum ACE activity, and diabetic retinopathy in type II diabetic patients. Hunan Yi Ke Da Xue Xue Bao 1999;24:33-36.
44. Matsumoto A, Iwashima Y, Abiko A, et al. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Diabetes Research and Clinical Practice 2000;50:195-202.
45. Araz M, Yilmaz N, Gungor K, et al. Angiotensin-converting enzyme gene poly- morphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Research and Clinical Practice 2001;54:95-104.
46. Moleda P, Majkowska L, Safranow K, et al. Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients. Przegl Lek 2007;64:134-139.
47. Scharplatz M, Puhan MA, Steurer J, et al. Does the Angiotensin- converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?-A systematic review. Currernt Control Trials in Cardiovascular Medicine 2005;6:16.
48. Larochelle P, Genest J, Kuchel O, et al. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Canadian Medical Association Journal 1979;121:309-316.
49. Fyhrquist F, Gronhagen-Riska C, Hortling L, et al. Regulation of angiotensin converting enzyme. Journal of Hypertension Suppl 1983;1:25-30.
50. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990;16:363-370.
51. Juillerat L, Nussberger J, Menard J, et al. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990;16:564-572.
52. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. American Journal of Human Genetics 1992;51:197-205.
53. Liao L, Lei MX, Chen HL, Guo LJ, Han XY. Angiotensin converting enzyme gene polymorphism and type 2 diabetic retinopathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004;29:410-413.